Independent Advisor Alliance Abb Vie Inc. Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Abb Vie Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 116,337 shares of ABBV stock, worth $20.9 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

116,337

Previous 116,997 0.56%

Holding current value

$20.9 Million

Previous $20.1 Million 14.49%

% of portfolio

0.85%

Previous 0.7%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $108,134 - $131,557	-660 Reduced 0.56%	116,337 $23 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $401,680 - $469,072	2,595 Added 2.27%	116,997 $20.1 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $1.08 Million - $1.23 Million	-6,765 Reduced 5.58%	114,402 $20.8 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $65,084 - $73,300	473 Added 0.39%	121,167 $18.8 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $447,526 - $518,077	-3,350 Reduced 2.7%	120,694 $18 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $169,480 - $210,907	-1,279 Reduced 1.02%	124,044 $16.7 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $444,820 - $512,277	3,076 Added 2.52%	125,323 $20 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $617,000 - $739,946	-4,461 Reduced 3.52%	122,247 $19.8 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $1.54 Million - $1.76 Million	-11,439 Reduced 8.28%	126,708 $17 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $2.39 Million - $3.03 Million	17,335 Added 14.35%	138,147 $21.2 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $1.57 Million - $1.95 Million	11,891 Added 10.92%	120,812 $19.6 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $866,852 - $1.1 Million	8,069 Added 8.0%	108,921 $14.7 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $143,214 - $162,569	1,346 Added 1.35%	100,852 $10.9 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $1.58 Million - $1.76 Million	-15,008 Reduced 13.11%	99,506 $11.2 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $1.18 Million - $1.3 Million	11,509 Added 11.17%	114,514 $12.4 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $584,276 - $788,835	7,259 Added 7.58%	103,005 $11 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $4.48 Million - $5.26 Million	52,203 Added 119.89%	95,746 $8.39 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $563,481 - $754,022	7,680 Added 21.41%	43,543 $4.28 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $277,156 - $420,203	-4,297 Reduced 10.7%	35,863 $2.73 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $129,473 - $161,998	-1,795 Reduced 4.28%	40,160 $3.56 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $156,190 - $187,785	-2,480 Reduced 5.58%	41,955 $3.21 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $209,648 - $267,980	-3,191 Reduced 6.7%	44,435 $2.89 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $373,049 - $439,060	4,836 Added 11.3%	47,626 $3.84 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $138,105 - $170,321	-1,774 Reduced 3.98%	42,790 $3.89 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $425,345 - $472,850	4,784 Added 12.03%	44,564 $3.89 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $338,919 - $401,018	3,775 Added 10.48%	39,780 $3.35 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $114,552 - $153,396	1,245 Added 3.58%	36,005 $3.29 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $854,939 - $937,512	9,546 Added 37.86%	34,760 $3.46 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $383,686 - $490,085	5,493 Added 27.85%	25,214 $2.29 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,721	19,721 $1.42 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Abb Vie Inc. Transaction History